Qualigen Therapeutics Inc (QLGN)
0.301
+0.01
(+3.69%)
USD |
NASDAQ |
May 03, 16:00
0.3067
+0.01
(+1.89%)
After-Hours: 20:00
Qualigen Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 2.509 |
| September 28, 2023 | 2.434 |
| September 27, 2023 | 2.558 |
| September 26, 2023 | 2.583 |
| September 25, 2023 | 2.434 |
| September 22, 2023 | 2.534 |
| September 21, 2023 | 2.527 |
| September 20, 2023 | 2.459 |
| September 19, 2023 | 2.410 |
| September 18, 2023 | 2.558 |
| September 15, 2023 | 2.608 |
| September 14, 2023 | 2.442 |
| September 13, 2023 | 2.427 |
| September 12, 2023 | 2.360 |
| September 11, 2023 | 2.409 |
| September 08, 2023 | 2.397 |
| September 07, 2023 | 2.509 |
| September 06, 2023 | 2.534 |
| September 05, 2023 | 2.534 |
| September 01, 2023 | 2.509 |
| August 31, 2023 | 2.583 |
| August 30, 2023 | 2.459 |
| August 29, 2023 | 2.520 |
| August 28, 2023 | 2.487 |
| August 25, 2023 | 2.525 |
| Date | Value |
|---|---|
| August 24, 2023 | 2.583 |
| August 23, 2023 | 2.534 |
| August 22, 2023 | 2.658 |
| August 21, 2023 | 2.609 |
| August 18, 2023 | 2.683 |
| August 17, 2023 | 2.560 |
| August 16, 2023 | 2.633 |
| August 15, 2023 | 2.715 |
| August 14, 2023 | 2.608 |
| August 11, 2023 | 2.558 |
| August 10, 2023 | 2.791 |
| August 09, 2023 | 2.658 |
| August 08, 2023 | 2.782 |
| August 07, 2023 | 2.906 |
| August 04, 2023 | 2.906 |
| August 03, 2023 | 3.006 |
| August 02, 2023 | 2.804 |
| August 01, 2023 | 2.807 |
| July 31, 2023 | 2.807 |
| July 28, 2023 | 2.906 |
| July 27, 2023 | 2.807 |
| July 26, 2023 | 2.650 |
| July 25, 2023 | 2.444 |
| July 24, 2023 | 2.583 |
| July 21, 2023 | 2.583 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.409
Minimum
Dec 28 2022
6.872
Maximum
Nov 23 2021
2.027
Average
1.565
Median
Price to Book Value Benchmarks
| Marizyme Inc | -- |
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | 2.094 |
Price to Book Value Related Metrics
| Price | 0.301 |
| Earnings Yield | -883.7% |
| Market Cap | 1.898M |